We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Maxcyte Inc | LSE:MXCT | London | Ordinary Share | COM STK USD0.01 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 305.00 | 300.00 | 310.00 | 305.00 | 305.00 | 305.00 | 1,465 | 07:30:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 41.29M | -37.92M | -0.3664 | -10.21 | 387.11M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/3/2021 15:42 | Post 615...Stockready | assagai | |
14/3/2021 15:27 | Stock ready may not be ready to smile today | eaglebeagle | |
14/3/2021 15:00 | Which youtube? Are you referring to that stupid guy with sun glasses (funky finance) talking all loads of BS? REALLY!? Does any wise investors invest a penny based on those loads of utter BS that guy is throwing out his pram? No Unless i missed something or you mean a different youtube link | stockready | |
14/3/2021 14:53 | Stocktready, perhaps we should start with your first two pronouncements, both of which are fundamentally incorrect. The best thing to do is open the YouTube link above. Listen to that and then you may very well want to get onboard! Oh and I'll have a small wager that we will close on Friday above last Friday's close. | assagai | |
14/3/2021 13:14 | Can someone tell me why this rocketed up tbis much while their business is nothing new and other companies are doing this in larger scales? Does the recent corrections will continue? Thanks | stockready | |
12/3/2021 16:02 | This stock is seen by the UK market as being expensive based on current revenues. As soon as it lists on Nasdaq, the US market will see it as being ludicrously cheap based on future earnings. | someuwin | |
12/3/2021 13:19 | Apologies if not relevent but I hadn't noticed before that Maxcyte had a US OTC listing OTCMKTS: MAXC Anyway, it is good to note they have a Nasdaq page in preparation for a future listing.... | pob69 | |
12/3/2021 12:57 | Thanks. The blue sky dcf valuation they give is £24 and £12.40 the base case. | nimbo1 | |
12/3/2021 10:00 | Big upgrade from numis today - 1240p target - forecasting 100m sales by 2025 and I would say that will prove to be conservative - with the valuations the US attach to bio tech I would expect these to far exceed that target on after a few months on Nasdaq | matrixtrader | |
11/3/2021 22:21 | Direct link to the presentation on YouTube: | cooltools | |
11/3/2021 20:07 | 1 Billion m/c hopefully soon in the rear view mirror. Nicely put Doug, nicely put. | assagai | |
11/3/2021 15:35 | Don't forget to register for tonight's Proactive Forum. Maxcyte and my favourite small cap O&G stock UOG, amongst others. | someuwin | |
11/3/2021 15:09 | nice to have you on board Ron : ) | nimbo1 | |
11/3/2021 15:06 | Baron Capital on board... Another US fund Longer term investor | assagai | |
11/3/2021 13:49 | I've just come across this, looks compelling. In for a few. | zubes | |
11/3/2021 12:03 | Been buying a few more today. | someuwin | |
11/3/2021 08:20 | If you consider the price went down its highly likely those prints were delayed sells but it doesn't matter as clearly the price moves to where the buys match - for a short period we've had more sellers than buyers...unsurprisin | nimbo1 | |
10/3/2021 18:50 | Yeh jt must be. Look at those delayed buys. Absolutely hoovered up. Shame I didn’t see these whilst playing the trade down as the us corrected. | 2theduke | |
10/3/2021 18:20 | Was that a 3 million buy? Reckon most of the sells are being scooped up by the US funds? | hj996 | |
10/3/2021 16:44 | Well I don't know if that was the bottom today. Anyway could not resist a final tranche. 3000 @ 8.4775, not showing so I expect to see it recorded tomorrow....as a sell! | assagai | |
09/3/2021 21:03 | Updated note from Trinity This improving visibility prompts us to revisit our valuation methodology resulting in a substantial upgrade to £1bn (1217p/share) vs £310m (402p) before. | pob69 | |
08/3/2021 14:37 | Here is a reference to MXCT from today's article from River and Mercantile's Dan Hanbury, Head of Income and Smaller Companies (I hold) "....As we all know, pharmaceuticals companies have also been forced into the limelight like never before this year. However even pre-Covid, technology platforms like MaxCyte that supply Big Pharma were providing sustainable growth options to augment income funds, without the pricing and regulatory risk of Big Pharma themselves." | pob69 | |
07/3/2021 21:12 | Entertaining video highlighting MXCT investment opportunity (I hold and as he suggests it is a little reminicent of BVXP which I also hold) | pob69 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions